特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
969281

幹細胞の世界市場予測(2021年~2028年)

Global Stem Cell Market Forecast 2021-2028

出版日: | 発行: Inkwood Research | ページ情報: 英文 310 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
幹細胞の世界市場予測(2021年~2028年)
出版日: 2020年11月09日
発行: Inkwood Research
ページ情報: 英文 310 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の幹細胞の市場規模は、2021年から2028年の予測期間中に、7.82%のCAGRで成長すると予測されています。同市場の成長を促進する主な要因には、再生医療における幹細胞の需要の高まり、臍帯幹細胞に対する認識の高まり、幹細胞治療と調査への研究開発投資の急増、および技術の進歩などが挙げられます。

幹細胞は、傍分泌で創傷修復と皮膚組織の再生を促進するという点で、驚くべき可能性を秘めています。間葉系幹細胞として、多くの細胞型、胚性幹細胞、上皮幹細胞、常在組織幹細胞、造血幹細胞、脂肪由来幹細胞が現在広範囲にわたって研究されており、同市場の大幅な成長に貢献する可能性が見込まれています。

当レポートは、世界の幹細胞市場について調査しており、市場規模や推計、成長および抑制要因、COVID-19の影響、治療用途・製品・技術・用途・治療タイプ・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査範囲と調査手法

  • 調査目的
  • 調査範囲
  • 調査手法
  • 前提条件と制限

第2章 エグゼクティブサマリー

  • 市場規模・推計
  • 市場概要

第3章 市場力学

  • 主な成長要因
    • 再生医療における幹細胞の急増需要
    • 幹細胞治療と調査開発投資の拡大
    • 臍帯幹細胞に関する意識の高まり
    • 移植片における組織拒絶反応のリスクの低減
    • 技術の進歩
  • 主な抑制要因
    • 厳格な政府規制
    • 幹細胞治療に関連する高コスト
    • 幹細胞に関連する倫理的問題と社会的複雑性
    • 先進国における即応性の低下

第4章 主要な分析

  • ポーターのファイブフォース分析
  • COVID-19が幹細胞市場に与える影響
  • バリューチェーン分析
  • 主な購入基準
  • 幹細胞の歴史
  • 規制の枠組み
  • オポチュニティマトリックス
  • ベンダー情勢
  • 主な投資インサイト

第5章 治療用途別市場

  • 整形外科治療
  • 怪我や創傷
  • 腫瘍障害
  • 心血管障害
  • 神経学的障害
  • 糖尿病
  • その他の治療用途

第6章 製品別市場

  • 成体幹細胞
    • 造血幹細胞
    • 神経幹
    • 臍帯幹細胞
    • 間葉系幹細胞
    • 歯科用幹細胞
  • ヒト胚性幹細胞
  • 多能性
  • マウス/ラットニューロン

第7章 技術別市場

  • 採取
    • 幹細胞骨髄
    • 幹細胞アフェレーシス
    • 幹細胞臍帯
  • 凍結保存
  • 拡張とサブカルチャー
  • 製造
    • 幹細胞培養
    • 治療的クローニング
    • IVF

第8章 用途別市場

  • 再生医療
  • 創薬と開発

第9章 治療タイプ別の市場

  • 同種幹細胞治療
  • 自動幹細胞治療
  • 同系幹細胞治療

第10章 地域分析

  • 北米
    • 市場規模・推計
    • 主要な成長イネーブラー
    • 主な課題
    • 主要企業
    • 国の分析
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合情勢

  • 主な戦略的開発
    • 合併と買収
    • 製品の発売と開発
    • 提携、契約および協業
    • 事業拡大/承認/発表
  • 企業プロファイル
    • ALLCELLS LLC
    • BECTON, DICKINSON AND COMPANY (BD)
    • CORNING INC
    • CYTORI THERAPEUTICS
    • GE HEALTHCARE
    • INTERNATIONAL STEM CELL CORP
    • MERCK KGAA (SIGMA ALDRICH)
    • MILTENYI BIOTEC
    • PLURISTEM THERAPEUTICS INC
    • QIAGEN NV
    • SMITH & NEPHEW PLC
    • STEMCELL TECHNOLOGIES
    • STRYKER CORPORATION
    • TAKARA HOLDINGS INC
    • THERMO FISHER SCIENTIFIC INC
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - STEM CELL
  • TABLE 2: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL ADULT STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL ADULT STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL NEURAL STEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL NEURAL STEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL DENTAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL DENTAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL PLURIPOTENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL PLURIPOTENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL ACQUISITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL ACQUISITION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 49: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 51: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL CRYOPRESERVATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 53: GLOBAL CRYOPRESERVATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 55: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 57: GLOBAL PRODUCTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 59: GLOBAL PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL STEM CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 61: GLOBAL STEM CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 62: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 63: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 64: GLOBAL IVF MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 65: GLOBAL IVF MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 66: GLOBAL STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 67: GLOBAL STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 68: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 69: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 70: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 71: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 72: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 73: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 74: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 75: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 76: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 77: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 78: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 79: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 80: GLOBAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 81: GLOBAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 82: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 83: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 84: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET
  • TABLE 85: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 86: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 87: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET
  • TABLE 88: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 89: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 90: LEADING PLAYERS OPERATING IN ASIA PACIFIC STEM CELL MARKET
  • TABLE 91: REST OF WORLD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 92: REST OF WORLD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 93: LEADING PLAYERS OPERATING IN REST OF WORLD STEM CELL MARKET

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020
  • FIGURE 6: GLOBAL STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL STEM CELL MARKET, BY PRODUCT, IN 2020
  • FIGURE 14: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 24: GLOBAL STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL STEM CELL MARKET, BY APPLICATION, IN 2020
  • FIGURE 35: GLOBAL STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 36: GLOBAL STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, IN 2020
  • FIGURE 38: GLOBAL STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 39: GLOBAL STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 40: GLOBAL STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 41: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 42: UNITED STATES STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: CANADA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 45: GERMANY STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: FRANCE STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: UNITED KINGDOM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: ITALY STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: RUSSIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: BELGIUM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: POLAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: REST OF EUROPE STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 53: ASIA PACIFIC STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 54: CHINA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 55: JAPAN STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 56: INDIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 57: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 58: SOUTH KOREA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 59: THAILAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 60: INDONESIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 61: VIETNAM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 62: REST OF ASIA PACIFIC STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 63: REST OF WORLD STEM CELL MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 64: LATIN AMERICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 65: MIDDLE EAST & AFRICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
目次
Product Code: 4685

KEY FINDINGS

The global stem cell market is evaluated to grow with a CAGR of 7.82%, during the forecast period of 2021 to 2028. Primary factors driving the market growth include the rising demand for stem cells in regenerative medicine, growing awareness about umbilical cord stem cells, surging research and development investments in stem cell therapies and research, and technological advancements.

MARKET INSIGHTS

Stem cells possess remarkable potential, in terms of promoting wound repaid in a paracrine manner and cutaneous tissue regeneration. As mesenchymal stem cells, numerous cell types, embryonic stem cells, epithelial stem cells, resident tissue stem cells, hematopoietic stem cells, and adipose-derived stem cells are presently under extensive investigation. As a result, this is likely to contribute to the significant growth of the stem cell market.

Umbilical cord stem cells as a non-invasive and efficacious alternative source of hematopoietic stem cells are gaining added awareness and prevalence. They are primarily utilized for treating a varied range of blood-, metabolic-, bone-, and immune system-related disorders and diseases. Moreover, the knowledge regarding the importance of the umbilical cord, as well as its applications, especially across developed markets, is steadily increasing.

REGIONAL INSIGHTS

The global stem cell market growth analysis includes the Asia Pacific, Europe, North America, and the rest of the world. The Asia Pacific observes an increased incidence of chronic diseases, such as cancer, in addition to growing medical tourism in developing nations like India and China, as well as improved economic stability. As a result, the region is anticipated to be the fastest-growing market for stem cells.

COMPETITIVE INSIGHTS

Since stem cells play a crucial role in toxicology studies and drug discovery, the intensity towards optimizing the technical strength for stem cells is continually growing. This factor is also crucial in bolstering the growth of the companies operating in the market. Hence, the degree of competitive rivalry is anticipated to increase further, and remain high, over the forecast period. The market's key players include, Corning Inc, Becton, Dickinson and Company (BD), GE Healthcare, Smith & Nephew PLC, Qiagen NV, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING DEMAND OF STEM CELLS IN REGENERATIVE MEDICINE
    • 3.1.2. GROWING R&D INVESTMENTS IN STEM CELL THERAPIES AND RESEARCH
    • 3.1.3. RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
    • 3.1.4. REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
    • 3.1.5. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. STRINGENT GOVERNMENT REGULATIONS
    • 3.2.2. HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
    • 3.2.3. ETHICAL ISSUES AND SOCIAL COMPLEXITIES ASSOCIATED WITH STEM CELLS
    • 3.2.4. LESS RESPONSIVENESS IN DEVELOPED ECONOMIES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON STEM CELL MARKET
  • 4.3. VALUE CHAIN ANALYSIS
  • 4.4. KEY BUYING CRITERIA
  • 4.5. HISTORY OF STEM CELL
  • 4.6. REGULATORY FRAMEWORK
  • 4.7. OPPORTUNITY MATRIX
  • 4.8. VENDOR LANDSCAPE
  • 4.9. KEY INVESTMENT INSIGHTS

5. MARKET BY THERAPEUTIC APPLICATION

  • 5.1. ORTHOPEDIC TREATMENTS
  • 5.2. INJURIES AND WOUNDS
  • 5.3. ONCOLOGY DISORDERS
  • 5.4. CARDIOVASCULAR DISORDERS
  • 5.5. NEUROLOGICAL DISORDERS
  • 5.6. DIABETES
  • 5.7. OTHER THERAPEUTIC APPLICATIONS

6. MARKET BY PRODUCT

  • 6.1. ADULT STEM CELL
    • 6.1.1. HEMATOPOIETIC STEM CELL
    • 6.1.2. NEURAL STEM
    • 6.1.3. UMBILICAL CORD STEM CELL
    • 6.1.4. MESENCHYMAL STEM CELL
    • 6.1.5. DENTAL STEM CELL
  • 6.2. HUMAN EMBRYONIC STEM CELL
  • 6.3. PLURIPOTENT
  • 6.4. MOUSE/RAT NEURAL

7. MARKET BY TECHNOLOGY

  • 7.1. ACQUISITION
    • 7.1.1. STEM CELL BONE MARROW MARKET
    • 7.1.2. STEM CELL APHERESIS
    • 7.1.3. STEM CELL UMBILICAL CORD
  • 7.2. CRYOPRESERVATION
  • 7.3. EXPANSION AND SUB-CULTURE
  • 7.4. PRODUCTION
    • 7.4.1. STEM CELL CULTURE
    • 7.4.2. THERAPEUTIC CLONING
    • 7.4.3. IVF

8. MARKET BY APPLICATION

  • 8.1. REGENERATIVE MEDICINE
  • 8.2. DRUG DISCOVERY AND DEVELOPMENT

9. MARKET BY TREATMENT TYPE

  • 9.1. ALLOGENEIC STEM CELL THERAPY
  • 9.2. AUTOLOGIC STEM CELL THERAPY
  • 9.3. SYNGENEIC STEM CELL THERAPY

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. MARKET SIZE & ESTIMATES
    • 10.1.2. KEY GROWTH ENABLERS
    • 10.1.3. KEY CHALLENGES
    • 10.1.4. KEY PLAYERS
    • 10.1.5. COUNTRY ANALYSIS
      • 10.1.5.1. UNITED STATES
      • 10.1.5.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. MARKET SIZE & ESTIMATES
    • 10.2.2. KEY GROWTH ENABLERS
    • 10.2.3. KEY CHALLENGES
    • 10.2.4. KEY PLAYERS
    • 10.2.5. COUNTRY ANALYSIS
      • 10.2.5.1. GERMANY
      • 10.2.5.2. FRANCE
      • 10.2.5.3. UNITED KINGDOM
      • 10.2.5.4. ITALY
      • 10.2.5.5. RUSSIA
      • 10.2.5.6. BELGIUM
      • 10.2.5.7. POLAND
      • 10.2.5.8. REST OF EUROPE
  • 10.3. ASIA PACIFIC
    • 10.3.1. MARKET SIZE & ESTIMATES
    • 10.3.2. KEY GROWTH ENABLERS
    • 10.3.3. KEY CHALLENGES
    • 10.3.4. KEY PLAYERS
    • 10.3.5. COUNTRY ANALYSIS
      • 10.3.5.1. CHINA
      • 10.3.5.2. JAPAN
      • 10.3.5.3. INDIA
      • 10.3.5.4. AUSTRALIA & NEW ZEALAND
      • 10.3.5.5. SOUTH KOREA
      • 10.3.5.6. THAILAND
      • 10.3.5.7. INDONESIA
      • 10.3.5.8. VIETNAM
      • 10.3.5.9. REST OF ASIA PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. MARKET SIZE & ESTIMATES
    • 10.4.2. KEY GROWTH ENABLERS
    • 10.4.3. KEY CHALLENGES
    • 10.4.4. KEY PLAYERS
    • 10.4.5. REGIONAL ANALYSIS
      • 10.4.5.1. LATIN AMERICA
      • 10.4.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. KEY STRATEGIC DEVELOPMENTS
    • 11.1.1. MERGER & ACQUISITIONS
    • 11.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 11.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 11.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 11.2. COMPANY PROFILE
    • 11.2.1. ALLCELLS LLC
    • 11.2.2. BECTON, DICKINSON AND COMPANY (BD)
    • 11.2.3. CORNING INC
    • 11.2.4. CYTORI THERAPEUTICS
    • 11.2.5. GE HEALTHCARE
    • 11.2.6. INTERNATIONAL STEM CELL CORP
    • 11.2.7. MERCK KGAA (SIGMA ALDRICH)
    • 11.2.8. MILTENYI BIOTEC
    • 11.2.9. PLURISTEM THERAPEUTICS INC
    • 11.2.10. QIAGEN NV
    • 11.2.11. SMITH & NEPHEW PLC
    • 11.2.12. STEMCELL TECHNOLOGIES
    • 11.2.13. STRYKER CORPORATION
    • 11.2.14. TAKARA HOLDINGS INC
    • 11.2.15. THERMO FISHER SCIENTIFIC INC
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.